Literature DB >> 16877860

Immune reconstitution syndrome in a child with TB and HIV.

G Narendran1, Soumya Swaminathan, S Sathish, S Rajasekaran.   

Abstract

Immune reconstitution syndrome (IRS) is the transient worsening or appearance of new signs, symptoms or radiological manifestation of an opportunistic infection occurring after the initiation of Highly active antiretroviral therapy (HAART) and is not due to treatment failure or new infection. We describe a case of a HIV infected child with tubercular (mediastinal) lymphadenitis with worsening of clinical and radiological features on starting HAART.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16877860     DOI： 10.1007/bf02759931

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


  7 in total

Review 1.  Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy.

Authors:  W J Burman; B E Jones
Journal:  Am J Respir Crit Care Med       Date:  2001-07-01       Impact factor: 21.405

Review 2.  Immune restoration disease after antiretroviral therapy.

Authors:  Martyn A French; Patricia Price; Shelley F Stone
Journal:  AIDS       Date:  2004-08-20       Impact factor: 4.177

3.  Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

Authors:  M Narita; D Ashkin; E S Hollender; A E Pitchenik
Journal:  Am J Respir Crit Care Med       Date:  1998-07       Impact factor: 21.405

4.  Immune reconstitution syndrome following initiation of antiretroviral therapy in a patient with HIV infection and multidrug-resistant tuberculosis.

Authors:  Soumya Swaminathan; C Padmapriyadarsini; G Narendran; Beena E Thomas; S Anand; Aishwarya Rajyalakshmi
Journal:  Indian J Chest Dis Allied Sci       Date:  2005 Oct-Dec

5.  Paradoxical worsening of tuberculosis in HIV-infected persons.

Authors:  K A Wendel; K S Alwood; R Gachuhi; R E Chaisson; W R Bishai; T R Sterling
Journal:  Chest       Date:  2001-07       Impact factor: 9.410

6.  Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India.

Authors:  N Kumarasamy; Sreekanth Chaguturu; Kenneth H Mayer; Suniti Solomon; H Tokugha Yepthomi; Pachamuthu Balakrishnan; Timothy P Flanigan
Journal:  J Acquir Immune Defic Syndr       Date:  2004-12-15       Impact factor: 3.731

7.  Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection.

Authors:  R A M Breen; C J Smith; H Bettinson; S Dart; B Bannister; M A Johnson; M C I Lipman
Journal:  Thorax       Date:  2004-08       Impact factor: 9.139
  7 in total
  5 in total

1.  Development of a culturally appropriate health-related quality of life measure for human immunodeficiency virus-infected children in Thailand.

Authors:  Warunee Punpanich; Ron D Hays; Roger Detels; Kulkanya Chokephaibulkit; Umaporn Chantbuddhiwet; Pimsiri Leowsrisook; Wasana Prasitsuebsai
Journal:  J Paediatr Child Health       Date:  2010-10-26       Impact factor: 1.954

2.  Immune Reconstitution Syndrome in HIV-1 infected children - a study from India.

Authors:  Ira Shah
Journal:  Indian J Pediatr       Date:  2011-01-04       Impact factor: 1.967

3.  Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in children.

Authors:  Annelies Van Rie; Shobna Sawry; Ruth Link-Gelles; Shabir Madhi; Lee Fairlie; Charl Verwey; Nasreen Mahomed; David Murdoch; Harry Moultrie
Journal:  Pediatr Pulmonol       Date:  2015-06-14

Review 4.  Tuberculosis Immune Reconstitution Inflammatory Syndrome in children initiating Antiretroviral Therapy for HIV infection: A systematic literature review.

Authors:  Ruth Link-Gelles; Harry Moultrie; Shobna Sawry; David Murdoch; Annelies Van Rie
Journal:  Pediatr Infect Dis J       Date:  2014-05       Impact factor: 2.129

5.  Does CD4+CD25+foxp3+ cell (Treg) and IL-10 profile determine susceptibility to immune reconstitution inflammatory syndrome (IRIS) in HIV disease?

Authors:  Esaki Muthu Shankar; Ramachandran Vignesh; Vijayakumar Velu; Kailapuri G Murugavel; Ramalingam Sekar; Pachamuthu Balakrishnan; Charmaine Ac Lloyd; Shanmugam Saravanan; Suniti Solomon; Nagalingeswaran Kumarasamy
Journal:  J Inflamm (Lond)       Date:  2008-02-18       Impact factor: 4.981
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.